Efficacy of synthetic antimicrobial peptides against Liberibacter crescens and Xylella fastidiosa
Text Complet
Compartir
Xylella fastidiosa and Candidatus Liberibacter are two highly widespread phytopathogens
throughout the world that cause multiple diseases having a huge economic impact on
agriculture. Although multiple studies aiming to controll these pathogens, no therapeutic
solutions have been found for its reduction or suppression in infected plants. Antimicrobial
peptides were identified as possible candidates of treating and preventing diseases caused by
these pathogens because of their low cytotoxicity and wide range of antibacterial activity
against a variety of phytopathogens. Antibacterial, bactericidal and viability assessment allow
to identify AMP with high antibacterial activity against Liberibacter crescens. BP5, BP3, BP24
and BP31 are among AMPs that exhibited strong antibacterial activity against Liberibacter
crescens, with MIC values in the range of 6.25-50 µM. BP5 has the overall highest antibacterial
activity and has been selected to be tested in planta for the control of Candidatus Liberibacter
in citrus plants. In parallel, a combined peptide treatment strategy (preventive and curative)
confirmed that BP2 controls the growth of Xylella fastidiosa subsp. pauca in Nicotiana
benthamiana plants, 24 days after pathogen inoculation